FDA Inspection 1105865 — Biomat USA Inc

Biomat USA Inc — FEI 3000210606

The FDA completed an inspection of Biomat USA Inc on August 1, 2019 in Rexburg, ID. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 1, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Rexburg, ID (United States)